Manuel J. Velez

Intellectual Property Counseling & Prosecution, Trademark Litigation, Intellectual Property


Manuel Velez serves clients on patent infringement litigations and PTAB proceedings regarding pharmaceuticals, biotechnology, and medical devices. His experience runs the full gamut, from conducting pre-case assessments to managing litigations for innovator companies in high-stakes cases in federal courts. Manuel has been a member of trial teams that obtained favorable trial decisions and settlements for branded pharmaceutical clients in Hatch-Waxman and BPCIA litigations. He performs due diligence in connection with M&A transactions, including providing freedom-to-operate opinions.



  • Gilead in performing due diligence in connection with collaboration agreement with Lyndra Therapeutics to develop ultra-long-acting HIV therapeutics.
  • Gilead in performing due diligence in connection with collaboration agreement with Nurix Therapeutics to create new cancer medicines that break down disease-causing proteins.
  • IMS in performing due diligence in connection with six separate acquisitions. Work included analyzing the intellectual property portfolio and contracts relating to intellectual property assets.


  • Manuel was shortlisted as a US Rising Star in Intellectual Property by the LMG Life Sciences Awards.
  • Recognized as a leading Patent litigator by IAM Patent 1000.

Formação Acadêmica

  • Boston University School of Law, JD
    Merit-Based Tuition Scholarship; Article Editor of Public Interest Law Journal, Recipient of Faculty Academic Progress Award, Equal Justice America Fellowship
  • University of Florida, MS
    Florida Georgia Alliance Graduate Fellowship
  • University of Florida, PhD
    National Science Foundation Pre-Doctoral Fellowship
  • Cornell University, BA
    Dean's List


  • New York


  • US District Court for the District of Puerto Rico


  • Espanhol
  • Francês


  • New York State Bar Association.